CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 38 filers reported holding CYTEIR THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | – | 332 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 4,840,413 | $84,949,000 | 4.39% |
| ACUTA CAPITAL PARTNERS, LLC | 391,974 | $6,879,000 | 2.43% |
| Ally Bridge Group (NY) LLC | 319,538 | $5,608,000 | 1.65% |
| RA Capital Management | 3,350,506 | $58,801,000 | 0.82% |
| Avidity Partners Management LP | 1,683,441 | $29,544,000 | 0.66% |
| Sofinnova Investments, Inc. | 246,321 | $4,323,000 | 0.26% |
| CAAS CAPITAL MANAGEMENT LP | 579,746 | $10,175,000 | 0.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 135,145 | $2,372,000 | 0.20% |
| ACT CAPITAL MANAGEMENT, LLC | 15,000 | $263,000 | 0.14% |
| Baker Brothers Advisors | 812,640 | $14,262,000 | 0.06% |